TIME last month released its "TIME 100 Most Influential Companies" list, which recognizes the companies and organizations "making an extraordinary impact around the world"—and includes several health care organizations.
The Biden administration on Tuesday announced a plan to increase the supply of Paxlovid, a Covid-19 antiviral made by Pfizer, throughout the United States. But many experts say supply of the drug isn't the problem—it's a lack of awareness and hesitance from the public.
A New Jersey high school is currently investigating a potential cancer cluster of more than 100 brain tumor diagnoses among students and staff over almost three decades—but experts warn that pinpointing an exact cause will likely be difficult.
Colorado recently launched an initiative asking insurers that offer certain health plans to collect demographic information from health professionals and enrollees—a move that some health care workers say could threaten their safety, Markian Hawryluk reports for Kaiser Health News. According to Advisory Board's health equity experts, there are ways to balance provider representation and patient choice beyond demographic disclosure.
The Department of Justice last week moved to appeal a federal judge's ruling against CDC's mask mandate for public transit—and legal experts say the agency may be aiming to "wipe [the ruling] off the books" rather than reverse it to reinstate masking requirements.
CMS last week issued a proposed rule that would expand access to Medicare special enrollment periods, in today's bite-sized hospital and health industry news from the District of Columbia, Illinois, and Maryland.
Print All Daily Briefing Article from
04/26/2022
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
